Now that we have had some time to review the FDA’s recent decision to approve the Libre2 we still have more questions than we do have answers. Such as why did it earn an iCGM designation when it cannot be used with an automated insulin delivery system? Why is Abbott who should be happy to have this approval igoing around trying to discredit Dexcom falsely claiming Libre2 is somehow better than the G6.
Let’s start with iCGM which according to the FDA means;
“An integrated continuous glucose monitoring system (iCGM) is intended to automatically measure glucose in bodily . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.